CytoDyn Inc (CYDY)
0.15
0.00 (0.00%)
USD |
OTCM |
Apr 19, 09:50
CytoDyn Cash from Financing (TTM): 9.657M for Feb. 29, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
February 29, 2024 | 9.657M |
November 30, 2023 | 20.75M |
August 31, 2023 | 22.43M |
May 31, 2023 | 29.93M |
February 28, 2023 | 36.46M |
November 30, 2022 | 26.29M |
August 31, 2022 | 55.18M |
May 31, 2022 | 48.01M |
February 28, 2022 | 92.61M |
November 30, 2021 | 96.61M |
August 31, 2021 | 96.77M |
May 31, 2021 | 137.35M |
February 28, 2021 | 121.42M |
November 30, 2020 | 136.26M |
August 31, 2020 | 111.07M |
May 31, 2020 | 79.67M |
February 29, 2020 | 54.55M |
November 30, 2019 | 46.73M |
August 31, 2019 | 53.78M |
May 31, 2019 | 52.75M |
February 28, 2019 | 44.58M |
November 30, 2018 | 42.68M |
August 31, 2018 | 35.67M |
May 31, 2018 | 29.35M |
February 28, 2018 | 27.24M |
Date | Value |
---|---|
November 30, 2017 | 21.34M |
August 31, 2017 | 23.98M |
May 31, 2017 | 18.88M |
February 28, 2017 | 22.42M |
November 30, 2016 | 32.64M |
August 31, 2016 | 27.45M |
May 31, 2016 | 33.41M |
February 29, 2016 | 32.36M |
November 30, 2015 | 16.14M |
August 31, 2015 | 15.23M |
May 31, 2015 | 8.199M |
February 28, 2015 | 3.816M |
November 30, 2014 | 2.027M |
August 31, 2014 | 10.81M |
May 31, 2014 | 11.69M |
February 28, 2014 | 13.63M |
November 30, 2013 | 13.84M |
August 31, 2013 | 7.902M |
May 31, 2013 | 7.215M |
February 28, 2013 | 6.038M |
November 30, 2012 | 9.062M |
August 31, 2012 | 3.831M |
May 31, 2012 | 3.638M |
February 29, 2012 | 4.662M |
November 30, 2011 | 2.355M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
9.657M
Minimum
Feb 2024
137.35M
Maximum
May 2021
66.41M
Average
54.16M
Median
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Ampio Pharmaceuticals Inc | 0.00 |